Solving the Problem of Insolubility: Part II
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
False
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 15, 2026
8 min read
Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace
October 14, 2026
12 min read
Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development
October 12, 2026
8 min read
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
October 7, 2026
2 min read
Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear
False
Affiliations:
Specialties:
Areas of Expertise: